Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of natalizumab in children with multiple sclerosis.
Ghezzi A, Pozzilli C, Grimaldi LM, Brescia Morra V, Bortolon F, Capra R, Filippi M, Moiola L, Rocca MA, Rottoli M, Sarchielli P, Zaffaroni M, Comi G. Ghezzi A, et al. Among authors: zaffaroni m. Neurology. 2010 Sep 7;75(10):912-7. doi: 10.1212/WNL.0b013e3181f11daf. Neurology. 2010. PMID: 20820002 Free article. Clinical Trial.
Epilepsy in multiple sclerosis.
Ghezzi A, Montanini R, Basso PF, Zaffaroni M, Massimo E, Cazzullo CL. Ghezzi A, et al. Among authors: zaffaroni m. Eur Neurol. 1990;30(4):218-23. doi: 10.1159/000117350. Eur Neurol. 1990. PMID: 2209677
Prospective study of multiple sclerosis with early onset.
Ghezzi A, Pozzilli C, Liguori M, Marrosu MG, Milani N, Milanese C, Simone I, Zaffaroni M. Ghezzi A, et al. Among authors: zaffaroni m. Mult Scler. 2002 Apr;8(2):115-8. doi: 10.1191/1352458502ms786oa. Mult Scler. 2002. PMID: 11990867
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study.
Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani N, Milanese C, Moiola L, Patti F, Pilato V, Pozzilli C, Trojano M, Zaffaroni M, Comi G; Immunomodulatory Treatment of Early onset MS Group. Ghezzi A, et al. Among authors: zaffaroni m. Mult Scler. 2005 Aug;11(4):420-4. doi: 10.1191/1352458505ms1206oa. Mult Scler. 2005. PMID: 16042224 Clinical Trial.
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.
Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu MG, Martinelli V, Milanese C, Moiola L, Milani N, La Mantia L, Patti F, Pozzilli C, Trojano M, Comi G, Zaffaroni M; Immunomodulatory Treatment of Early-onset MS (ITEMS) Group. Ghezzi A, et al. Among authors: zaffaroni m. Neurol Sci. 2007 Jun;28(3):127-32. doi: 10.1007/s10072-007-0804-2. Epub 2007 Jun 30. Neurol Sci. 2007. PMID: 17603763 Clinical Trial.
349 results